Literature DB >> 16598706

A natural history model of stage progression applied to breast cancer.

Sylvia K Plevritis1, Peter Salzman, Bronislava M Sigal, Peter W Glynn.   

Abstract

Invasive breast cancer is commonly staged as local, regional or distant disease. We present a stochastic model of the natural history of invasive breast cancer that quantifies (1) the relative rate that the disease transitions from the local, regional to distant stages, (2) the tumour volume at the stage transitions and (3) the impact of symptom-prompted detection on the tumour size and stage of invasive breast cancer in a population not screened by mammography. By symptom-prompted detection, we refer to tumour detection that results when symptoms appear that prompt the patient to seek clinical care. The model assumes exponential tumour growth and volume-dependent hazard functions for the times to symptomatic detection and stage transitions. Maximum likelihood parameter estimates are obtained based on SEER data on the tumour size and stage of invasive breast cancer from patients who were symptomatically detected in the absence of screening mammography. Our results indicate that the rate of symptom-prompted detection is similar to the rate of transition from the local to regional stage and an order of magnitude larger than the rate of transition from the regional to distant stage. We demonstrate that, in the even absence of screening mammography, symptom-prompted detection has a large effect on reducing the occurrence of distant staged disease at initial diagnosis. 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 16598706     DOI: 10.1002/sim.2550

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  17 in total

Review 1.  Calibration methods used in cancer simulation models and suggested reporting guidelines.

Authors:  Natasha K Stout; Amy B Knudsen; Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

2.  Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.

Authors:  John T Schousboe; Karla Kerlikowske; Andrew Loh; Steven R Cummings
Journal:  Ann Intern Med       Date:  2011-07-05       Impact factor: 25.391

3.  A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers.

Authors:  Bronislava M Sigal; Diego F Munoz; Allison W Kurian; Sylvia K Plevritis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-03       Impact factor: 4.254

4.  Online tool to guide decisions for BRCA1/2 mutation carriers.

Authors:  Allison W Kurian; Diego F Munoz; Peter Rust; Elizabeth A Schackmann; Michael Smith; Lauren Clarke; Meredith A Mills; Sylvia K Plevritis
Journal:  J Clin Oncol       Date:  2012-01-09       Impact factor: 44.544

5.  Cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.

Authors:  Sun Hee Rim; Benjamin T Allaire; Donatus U Ekwueme; Jacqueline W Miller; Sujha Subramanian; Ingrid J Hall; Thomas J Hoerger
Journal:  Cancer Causes Control       Date:  2019-05-16       Impact factor: 2.506

6.  Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality.

Authors:  Thomas J Hoerger; Donatus U Ekwueme; Jacqueline W Miller; Vladislav Uzunangelov; Ingrid J Hall; Joel Segel; Janet Royalty; James G Gardner; Judith Lee Smith; Chunyu Li
Journal:  Am J Prev Med       Date:  2011-04       Impact factor: 5.043

7.  Development and evaluation of a method for tumor growth simulation in virtual clinical trials of breast cancer screening.

Authors:  Hanna Tomic; Anna Bjerkén; Gustav Hellgren; Kristin Johnson; Daniel Förnvik; Sophia Zackrisson; Anders Tingberg; Magnus Dustler; Predrag R Bakic
Journal:  J Med Imaging (Bellingham)       Date:  2022-06-06

8.  Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance.

Authors:  Paul L Crispen; Rosalia Viterbo; Stephen A Boorjian; Richard E Greenberg; David Y T Chen; Robert G Uzzo
Journal:  Cancer       Date:  2009-07-01       Impact factor: 6.860

9.  Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study.

Authors:  Jeanette K Birnbaum; Catherine Duggan; Benjamin O Anderson; Ruth Etzioni
Journal:  Lancet Glob Health       Date:  2018-08       Impact factor: 26.763

10.  Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.

Authors:  Elizabeth A Schackmann; Diego F Munoz; Meredith A Mills; Sylvia K Plevritis; Allison W Kurian
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.